Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Wild, Hanno; Kolkhof, Peter; Oehme, Felix; Thede, Kai; Stoll, Friederike; Erguden, Jens-Kerim; Beck, Hartmut; Flamme, Ingo; Akbaba, Metin; Keldenich, Jorg; Jeske, Mario; Schuhmacher, Joachim

Agent Davies Collison Cave

Pub. Number AU-A-2007328052

PCT Pub. Number WO2008/067871

Priority 10 2006 050 516.6 26.10.06 DE

Filing date 12 October 2007

Wipo publication date 12 June 2008

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group